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ABSTRACT Epstein-Barr virus (EBV) DNA was analyzed for
the presence of autonomous replicating sequences (designated ars)
in a eukaryotic system consisting of a uracil auxotroph of Saccha-
romyces cerevae, YNN27, and a pBR322 hybrid plasmid, YIp5,
containing the yeast uracil gene but apparently lacking a eukar-
yotic origin of replication. Cloned EBV DNA EcoRI restriction
fragments, A, B, and DIJhet, were judged to function in this ca-
pacity by their ability to convert YNN27 cells to the uracil phe-
notype after transformation with each EBV-specific fragment li-
gated into YIp5. Additional analyses to confirm and to specify further
the location of the ans were performed by cleavage of EcoRI frag-
ments A and B into smaller BamHI fragments, which were sub-
sequently cloned in YIp5 and tested for their ability to function as
ars. BamHI fragment X, obtained from EcoRI fragment A, and
BamHI fragment R, obtained from EcoRI fragment B, showed at-
behavior. The successful recovery of the appropriate virus DNA
segments in plasmid form from transformed yeast cells and the
ability of these yeast cells to be propagated further substantiated
the ars capability of the three EBV fragments.
The plasmid form of the Epstein-Bar virus (EBV) genome is a
covalently closed circular molecule that exists only intracellu-
larly. Since its discovery, an understanding of the mechanism
whereby the EBV plasmid is maintained in cells has remained
an attractive but elusive objective (1, 2). The replication of the
EBV plasmid is strictly regulated in synchrony with the cell cycle;
the plasmid replicates only during the S phase, and the copy
number is constant and remains relatively low (3). The plasmid
is situated in the nucleus and exhibits a nucleosomal arrange-
ment (4). Circular EBV genomes are found both in cell lines and
in fresh tissue samples of Burkitt lymphoma and nasopharyn-
geal carcinoma (5). The plasmid is the only form of the EBV ge-
nome found in nonvirus-producing cell lines, but plasmids are
also found in the nonproductive cellular fraction of virus-pro-
ducing lines (6).
One of the intriguing aspects of EBV plasmids is that they are
believed to be replicated by host DNA polymerase rather than
virus-induced DNA polymerase (2). The viral enzyme is re-
sponsible for replication of the linear form of the EBV genome,
which is encapsulated in virions; the enzyme is not detectable
in the nonvirus-producing Raji cell line (7). In addition, the lin-
ear form of the EBV genome replicates independently of the
host-cell cycle, and the relative number of virus genomes fluc-
tuates over a wide range (8). The controlled, limited replication
of the EBV plasmids, together with the absence of viral poly-
merase, suggests that this EBV DNA form is replicated by host
DNA polymerase.
The existence of specific sites at which the genomes of nu-
merous prokaryotes and several eukaryotic viruses initiate DNA
synthesis is accepted fact, and these sites have been termed origins
of replication (9). However, in eukaryotes the existence of such
defined origins of replication, while assumed, has not been
demonstrated clearly except in a limited number of small ex-
trachromosomal DNAs such as mitochondrial DNA in which
initiation occurs at only one site for the entire molecule or from
each strand (9, 10). Cellular and complex viral genomes (e.g.,
herpesviruses) may have some similarities in their replication;
therefore, viruses of this type may provide a more useful system
in which to study eukaryotic-like origins of replication. The EBV
plasmid in particular is likely to have and indeed may be the best
candidate to contain eukaryotic origins (2).
Recent advances in molecular cloning have produced a sys-
tem in yeast analogous to replication systems in prokaryotes that
can be utilized to screen eukaryotic DNA segments for their ability
to replicate autonomously (11-13). Stinchcomb et al (14) first
demonstrated the existence of eukaryotic DNA sequences that
could replicate in such a system. To date, several sources of eu-
karyotic DNAs have been found to contain sequences that can
replicate in this yeast system. Among these are Saccharomyces
cerevisiae, Neurospora crassa, Dictyostelium discoideum, Dro-
sophila melanogaster, Zea mays, and mitochondrial DNA. Those
DNA sequences that replicate in this manner have been re-
ferred to as autonomously replicating sequences (designated ars)
and are presumably functional eukaryotic origins of replication
(13). Several yeast genes coding for various amino acids and DNA
precursors paired with their corresponding yeast auxotrophs have
been isolated and used as the basic selective system to analyze
for the presence of ars in eukaryotic DNAs.
One of these systems utilizes the URA3 gene of S. cerevisiae
for selection (13). The plasmid of interest, YIp5, is a hybrid plas-
mid consisting of pBR322 and the URA3 gene of S. cerevisiae.
Therefore, YIp5 can be utilized in a yeast selective system and
can be grown and recovered in an Escherichia coli system as
well. In addition, YIp5 lacks a functional yeast origin of repli-
cation and cannot transform the corresponding URA auxotroph
of S. cerevisiae unless an exogenous ars is incorporated into the
plasmid. This system then provides the necessary screening
system for the detection of ars within unrelated DNAs. Recent
work fiom several laboratories has shown the validity of this yeast
vector system when used in this capacity (11-13, 15). We have
used this selection system in experiments designed to deter-
mine the number and location of ars in the genome of EBV.
MATERIALS AND METHODS
Source of EBV DNA. The preparation of bacterial clones of
virus DNA from the W91 strain ofEBV has been described else-
where (16). The subsequent growth, isolation, and purification
Abbreviation: EBV, Epstein-Barr virus.
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FIG. 1. Identification of EcoRI and BamIH fiagments of EBVDNA (W-91 DNA) that contain ars. The fragments were tested in the YIp5-YNN27
system for their ability to function as ars. *, Fragments containing ars; A, fragments tested but not containing ars.
of the various genomic fragments of EBV used in this study have
been described in detail (17).
Yeast Strain and Vector. The uracil auxotroph of S. cerevis-
iae, YNN27, and the hybrid yeast plasmid YIp5 were generously
supplied by Dr. Ron Davis of Stanford University. The con-
ditions used in the growth and maintenance of YNN27 have been
described (13).
Cloning of EBVDNA into YIp5. YIp5 contains single-cut sites
for the restriction enzymes EcoRI, BamHI, HindIII, and Sal I
and resistance genes for both tetracycline and ampicillin (13).
The cloning procedures used for this vector involved cleavage
of the EBV DNA and the YIp5 with the desired restriction en-
zyme, followed by rehybridization of the mixture of DNA mol-
ecules and ligation of the hybrid molecules with T4 ligase. After
the cells were made competent by the CaCl2 technique (18) and
E. coli strain HB101 was transformed, selection of vector-con-
taining inserts could be done on medium containing either tet-
racycline or ampicillin. Detection of the resultant clones con-
taining EBV DNA inserts was done by in situ hybridization with
the appropriate labeled DNA probe (19). Subsequent growth




Transformation of Yeast. DNA transformation of S. cere-
visiae was done in a manner essentially identical to that used in
the transformation of bacteria except for an initial digestion step
to convert the yeast cells to spheroplasts (12). The yeast cells
were then plated on minimal medium without uracil in the pres-
ence of sorbitol. YNN27 transformants to the URA' phenotype
were recognized by the production of colonies after several days;
these transformants can be quantitated as the number of col-
onies per Ag of input DNA (13).
Transformation of Bacteria. The method used for the trans-
formation of the E. coli strain HB101 was essentially that de-
scribed by Dagert and Ehrlich (18).
Isolation of EBV DNA-Containing Plasmids from Yeast.
YNN27 cells were incubated with Zymolyase (Kirin, Japan) at
a final concentration of 1-mg/ml in 1 M sorbitol/4 mM EDTA
for 1 hr at 30TC and subsequently lysed by osmotic shock. The
lysate was then incubated with proteinase K (final concentra-
tion, 100 ,ug/ml) at 45TC for 30 min. The total yeast DNA was
then precipitated by addition of ethanol and subsequently used
to transform E. coli strain HB101.
Detection of DNA by Hybridization. DNA samples of in-
terest were cleaved with the desired restriction enzyme, sep-
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FIG. 2. Recovery of EcoRI fragment DIJhet from transformed yeast cells. YNN27 cells were transformed with the EcoRI DIJhet fragment as de-
scribed. Total DNA was isolated and subsequently used to-transform E. coli strain HB101. The resultant plasmids were analyzed by Southern blot
analysis with purified 32P-labeled EBV EcoRI DIJhet fragment as probe. (A) Ethidium bromide-stained agarose gel of representative plasmids cleaved
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Fro. 4. Recovery ofBamHI fragment X from transformed yeast cells.
YNN27 cells were transformed with theBamHI fragment X, and total
DNA was isolated and subsequently used to transform E. coli strain
HB101. The resultant plasmids were analyzed by Southern blot anal-
ysis with purified 32P-labeled EBV BamHI fragment X as probe. (A)
Ethidium bromide-stained agarose gel of representative plasmids
cleaved withBamHI restriction enzyme. (B) Autoradiogram of blot hy-
bridization analysis of representative plasmids using labeled BamHI








FIG. 3. Determination ofspecificBamIl fragments present in clones
of EcoRI A (A) and B (B) fragments. EBV EcoRI A and B fragments
were cleaved with BamHI restriction enzyme, ligated into BamHI-di-
gested YIp5, and used to transform E. coli strain HB101. Purified plas-
mid DNA was labeled with [32P]dCTP by nick-translation and sub-
sequently hybridized to Southern blots ofBamHI-digested EBV EcoRI
fragment A or B. Specific BamHI fragments are designated by their
appropriate letter (see Fig. 1). (A) B-amHI clones hybridized to blots of
BamHI-digested EcoRI fragment A. (B) BamHI clones hybridized to
blots ofBamHI-digestedEcoRl B fragment. pBR, bacterial cloning vec-
tor present in all samples.
arated by agarose-gel electrophoresis, and blotted onto nitro-
cellulose as described by Southern (20). Hybridization conditions
and visualization of the resultant bands by autoradiography have
been described. Labeled probes of interest were prepared with
[32P]dCTP' (ICN) by the method of Rigby (21).
RESULTS
Screening of the EBV Genome for the Presence of ars. The
initial screening of the virus genome involved the use of MUA3
clones of EBV DNA EcoRI fragments that were ligated into
EcoRI-digested YIp5,, these clones were used to transform YNN27
and were observed for their ability to function as ars as judged
by the production of URA' yeast colonies. EBV EcoRI frag-
ments A, B, C, DIJhet, E, F, G, G2, and H, which comprise
greater than 95% of the virus genome, were assayed by this
method (Fig. 1). Three DNA segments, A, B, and DIJhet, were
found to function as ars by the successful conversion of YNN27
URA- to the URA' phenotype; the remaining EcoRI fragments
were determined to be negative based upon this criterion.
Demonstration of EBV DNA in Transformed Yeast. That
the hybrid YIp5-DIJhet plasmid was present in the YNN27-
transformed cells was demonstrated directly by recovery of such
plasmids after transformation of E. coli with total yeast DNA
isolated from the URBA cells. Fig. 2 shows agarose gels of EcoRI-
cleaved YIp5-DIJhet plasmids obtained by this method and the
subsequent blot hybridization of the 32P-labeled DIJhet to the
DNA fragments, indicating that the DIJhet fragment is indeed
present.
Location of ars Present in EBV Fragments A and B. As men-
tioned above, transformation of yeast with YIp5 plasmids con-
taining either fragmentA or B resulted in the production of URA'
colonies, but the two fragments were of such a size that the rel-
ative location of the ars was still unclear. This problem was by-
passed by the use of a second enzyme, BamHI, which cleaved
both EcoRI fragments A and B into six smaller fragments each
(see Fig. 1) and allowed ligation of the resultant fragments into
YIp5 (Fig. 3). Subsequent transformation of YNN27 cells with
B
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FIG. 5. Recovery ofBamIH figmentRfrom transformed yeast cells.
YNN27 cells were transformed with BamHI fragment R, and total DNA
was isolated and subsequently used to transform E. coli strain HB101.
The resultant plasmids were analyzed by Southern blot analysis with
purified 32P-labeled EBV BamHI fragment R as probe. (A) Ethidium
bromide-stained agarose gel of representative plasmids cleaved with
BamHI restriction enzyme. (B) Autoradiogram of blot hybridization
analysis of representative plasmids with labeled BamHI fragment R
as probe.
B
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Table 1. Transformation of URA- yeast (YNN27) with clones of
EBV DNA*
Time, days Colonies per
EBV DNA clone 3 5 8 Ag of DNA,t
EcoRI fragment At
8(C) - - - 0
13(H) - - - 0
14(H,V) - - - 0
15(F) - - - 0
18(X) +++ +++ +++ 8,50P
21(F,V) - - - 0
EcoRI fragment B*
2(K) - - - 0
17(Y) - - - 0
22(R) +++ +++ +++ 8,200
25(B,Y) - - - 0
27(E) - - - 0
DIJIet +++ +++ +++ 9,200
* YNN27 cells were transformed by each EBVDNA YIp5 plasmid. The
number of URA' YNN27 colonies was determined each of the times
indicated in column one for the number of colonies per yg of DNA for
each EBV DNA clone. The specific EBV DNA fragments are desig-
nated by the appropriate letters (in parentheses in column one) as
shown in Fig. 1.
t The quantitation of colonies is based upon the number of colonies ob-
served after plating and the ability of the resultant colonies to be
propagated upon restreaking; abortive colonies were not scored as
positive.
tDigested with Bamffl.
each of the purified plasmids revealed one ars-containing BamHI
fragment located in EcoRI fragment A and one in EcoRI frag-
ment B. As indicated in Fig. 1, these fragments were BamHI
X (present in EcoRI fragment A) and BamHI R (present in EcoRI
fragment B). The transformation frequency of BamHI fragment
X was 8,500 colonies per /ig of input DNA and for BamHI frag-
ment R was 8,200 colonies per ug of input DNA (see Table 1).
Transformation attempts with the remaining hybrid plasmids
resulted in the production of either no colonies or, in some cases,
various low levels of colonies, which proved to be abortive
transformants as evidenced by their inability to be propagated.
However, transformants produced by plasmids containing EcoRI
DIJbet, BamHI X, or BamHI R fragment could be propagated
upon restreaking and, therefore, were judged to act as true ars.
Recovery of BamHI Fragments from Transformed YNN27.
Total yeast DNA from URA+ yeast cells 4 days after transfor-
mation with BamHI fragments X and R was used to transform
HB101 under ampicillin selection. Figs. 4 and 5 show agarose
gels of BamHI-digested plasmids recovered by this method and
the subsequent blot hybridization of the fragments with the use
of purified 32P-labeled BamHI X and R that revealed the pres-
ence of the fragments in question.
Location and Quantitation ofEBV Autonomous Replicating
Sequences. Fig. 1 and Table 1 summarize the results obtained
in this study. As shown schematically in Fig. 1, the EBV genome
contains three segments that act as ars in this yeast system: EcoRI
DIJhet, BamHI X (in EcoRI fragment A), and BamHI R (in EcoRI
fragment B). All other EBV DNA fragments, both EcoRI and
BamHI fragments, failed to transform YNN27 cells to the URA+
phenotype and, therefore, presumably do not function as ars in
this system. Table 1 quantitates the three positive EBV frag-
ments on the basis of colonies produced per ,g of-input DNA.
DISCUSSION
Latency is the hallmark of herpesvirus infections, and the EBV
plasmid has been proposed to be possibly the molecular basis
of this biologic feature (5). So far, plasmid forms have been dem-
onstrated in several other herpesvirus systems in addition to EBV
(e.g., Herpesvirus samiri; ref. 22). The role of this molecular
form in these infections and in relation to the other diseases that
arise after exposure to EBV, such as Burkitt lymphoma and na-
sopharyngeal carcinoma, is unknown. For example, whether or
not the plasmid is transcribed and expressed in these conditions
remains unexplored (5).
Experiments of the type described above revealed the pres-
ence of three defined virus DNA segments that could function
as an ars in this system. These three EBV fragments, EcoRI
DIJhet, BamHI X, and BamHI R, all satisfied the necessary cri-
teria to be classified as ars; the high frequency of production of
transformed yeast colonies, the successful recovery of EBV DNA-
containing plasmids from transformed yeast cells, and the ability
of transformed yeast colonies to be propagated confirmed the
identifications.
EcoRI DIJhet is a cloned fragment comprising the fused ter-
mini of the linear DNA molecule and is found in this form nat-
urally only in the plasmid form of the virus genome. This frag-
ment consists of a variable number of direct tandem repeats of
a 0.45-kilobase segment of DNA and a stretch of unique DNA
sequences. BamHI fragments X and R, in contrast, are con-
tained within the interior of the molecule in both the linear and
plasmid forms of the EBV genome. The fact that these three
fragments are recognized as ars is of special importance because
of their apparent association with other important functions of
the virus genome.
In the case of BamHI X, a transcript is generated from this
fragment in several EBV-transformed lymphoblastoid cell lines
(23) that indicates the presence of an RNA polymerase recog-
nition site. This observation is most interesting because of the
recent hypothesis that points of DNA replication are related to
units of transcription (9). Also Hayward and co-workers (24) have
shown that BamHI fragment X contains sequences that are ho-
mologous to mammalian cell DNA sequences, although the sig-
nificance of this observation is unknown at this time. Likewise,
in some of these cell lines, stable polyribosomal transcripts are
found that originate from both the left- and right-hand DNA se-
quences immediately adjacent to BamHI fragment R (including
BamHI fragments Y, K, and B) and that have been associated
also with the generation of nonstandard or defective virus ge-
nomes isolated from several EBV-transformed cell lines. These
observations are of interest due to the close relationship be-
tween origins of replication and the production of defective vi-
rus genomes (25). These correlations, while certainly not con-
clusive, do lend support to the status of BamHI fragments X and
R as ars. Likewise the DIJhet fragment has been implicated in
the generation of defective DNA and also serves as a template
for the production of abundant RNA transcripts.
It should be stated at this point that, even though the above-
mentioned theories pertaining to the ars found in the EBV plas-
mid are feasible, the actual role of these fragments in the rep-
lication process is unknown and cannot be determined with any
degree of certainty based solely upon the above experiments.
However, these results have allowed-us to establish the possible
locations of origins of DNA synthesis. In order to resolve this
question, we have initiated work that should provide the nec-
essary authentication of the role of these ars in mammalian cells.
The most important aspect of the experiment will be to deter-
mine if those EBV DNA sequences containing putative origins
of replication will allow a stable extrachromosomal form of the
virus DNA to become established. The results of such exper-
iments should help to provide answers to the question of how
the EBV plasmid replicates and is maintained in cells.
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